News summary

Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All‐Cause Mortality

Source: Aging Cell • Published: 02 Oct 2026, 07:01

Summarized by Masters of Longevity from Aging Cell.

Multimodal ageing biomarkers and plasma proteomic patterns are examined in a research article, guiding readers toward methods and implications worth exploring.

Multimodal Ageing Biomarkers and Plasma Proteomic Signatures Associated With All‐Cause Mortality
Key Takeaways
  • A multimodal set of ageing biomarkers correlated with all-cause mortality across the study cohorts.
  • Specific plasma proteomic signatures were identified that associated significantly with future mortality risk.
  • Combining biomarker modalities improved mortality risk stratification compared with single-measure models.
Read the full article at Aging Cell ↗

Continue exploring

Recommended MoL Picks

MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.